Hisanori Hasegawa
Neurology · Fort Wayne, INNPI 1144311994
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,145 of the $4,532 with a category attached, or 69.4%. 39 manufacturers reported payments, led by Eisai CO., LTD. at 32.6% of the total. Reporting peaked in 2019 at $2,524 and has fallen 94.5% since, to $140 in 2024.
Across 207 payments — averaging $21.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai CO., LTD.$1K
- AbbVie$457
- Livanova USA, Inc.$209
- Amgen$202
- UCB, Inc.$196
- Supernus Pharmaceuticals, Inc.$169
- plus $2K from 33 others
What the payments were for
- Consulting fees$1,00022%
- Travel & lodging$3879%
- Food & beverage$3,14569%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai CO., LTD. | 4 | $1,478 |
| AbbVie | 52 | $457 |
| Livanova USA, Inc. | 7 | $209 |
| Amgen | 13 | $202 |
| UCB, Inc. | 8 | $196 |
| Supernus Pharmaceuticals, Inc. | 34 | $169 |
| Eisai Inc. | 9 | $165 |
| Novartis | 9 | $158 |
| Neurelis, Inc. | 5 | $149 |
| Abbott | 1 | $145 |
| Biogen | 8 | $129 |
| Lilly USA, LLC | 6 | $104 |
| Lundbeck LLC | 4 | $87 |
| Sunovion Pharmaceuticals Inc. | 5 | $77 |
| Argenx US, Inc. | 4 | $75 |
| Sanofi | 3 | $72 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $71 |
| SK Life Science, Inc. | 2 | $70 |
| CSL Behring | 2 | $45 |
| Catalyst Pharmaceuticals, Inc. | 2 | $40 |
| Impel Pharmaceuticals Inc. | 2 | $38 |
| Merz Pharmaceuticals, LLC | 1 | $33 |
| Avanir Pharmaceuticals, Inc. | 2 | $31 |
| MDD US Operations, LLC | 2 | $30 |
| Hospira, Inc. | 1 | $30 |
| Johnson & Johnson | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Genentech USA, Inc. | 1 | $27 |
| Acadia Pharmaceuticals Inc | 2 | $25 |
| Upsher-smith Laboratories LLC | 1 | $22 |
| Pfizer | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| AstraZeneca | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Promius Pharma LLC | 1 | $14 |
| Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fycompa$1,321
- Infinity DBS Pulse Generators$145
How this compares
$4,532 in reported general payments places this provider in the 60th percentile of 308 neurology providers in Indiana.
Other neurology in Fort Wayne
- Ajay GuptaFort Wayne$411K
- Marlene BultemeyerFort Wayne$277K
- Andrea HallerFort Wayne$242K
- Paul LaterFort Wayne$132K
- Christopher VachonFort Wayne$27K
- William ConteMerrillville$1.2M
- Anthony SimchakLafayette$720K
- Mark JanickiLebanon$573K
- Roderick WarrenEvansville$296K
- Ender AkanMunster$296K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.